Beta Bionics, Inc. (BBNX)

NGM – Real Time Price. Currency in USD

17.42

-0.20 (-1.11%)

Market open: Aug 12, 2026, 3:42 PM EDT

17.28

-0.34 (-1.91%)

Previous after-hours: Aug 11, 2026, 7:48 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

100M

65M

12M

179K

Cost of goods sold

-45M

-29M

-6M

-2M

Gross Profit

56M

36M

-2M

Operating expenses (excl. COGS)

-127M

-81M

-42M

-64M

Operating Income

-72M

-45M

-36M

-66M

Non-operating income, total

-2M

-10M

-8M

Pretax income

-73M

-55M

-44M

-65M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-73M

-55M

-44M

-65M

Discontinued operations

Net income

-73M

-55M

-44M

-65M

Dilution adjustment

Preferred dividends

Beta Bionics, Inc. (BBNX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Beta Bionics, Inc. (BBNX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Beta Bionics, Inc. (BBNX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Beta Bionics, Inc. (BBNX)

Income Statement (Annual)

Income Statement (Annual)